W44X mutation in the WWOX gene causes intractable seizures and developmental delay: a case report. Issue 1 (December 2016)

• Record Type: Journal Article
• Authors: Elsaadany, Loai; El-Said, Mahmoud; Ali, Rehab; Kamel, Hussein; Ben-Omran, Tawfeg
• Is Part Of: BMC medical genetics. Volume 17:Issue 1(2016)
• Page Start: 1
• Page End: 6
• Publication Date: 2016-12
• Subjects: WWOX -- W44X -- Seizure -- Encephalopathy -- Developmental delay -- Whole Exome Sequencing (WES); Medical genetics -- Periodicals; 616.04205
• DOI: 10.1186/s12881-016-0317-z
• Languages: English
• ISSNs: 1471-2350

Abstract

Abstract Background WW domain containing oxidoreductase (WWOX) gene was cloned in 2000; alteration has been seen in many cancer cells. It acts as a tumor suppresser by blocking cell growth and causing apoptosis. WWOX protein showed different expression of mice brain and spinal cord, for which deletion causes seizure and early death. Case presentation Clinical and molecular characteristics of a consanguineous family show a homozygous mutation of WWOX gene at specific bases, causing a debilitating syndrome characterized by growth retardation, intractable epilepsy, intellectual disability, and early death. Using Whole Exome Sequencing (WES), a novel homozygous mutation in the WWOX gene is identified in a consanguineous Arab family from Qatar with two daughters who presented with intractable seizure and developmental delay. Conclusion The study presents the importance of human WWOX gene for brain development and the association between gene mutation and epileptic encephalopathy. It also highlights the power of WES particularly in clinically challenging cases.